α2受體激動劑(可樂定)與抗毒蕈碱藥(奧昔布寧)聯合用於治療流涎
- 专利权人:
- ORIENT PHARMA (SAMOA) CO. LTD.
- 发明人:
- ROACH, Alan Geoffrey,GOLDSMITH, Paul,艾倫‧杰弗里‧羅奇,保羅‧戈德史密斯
- 申请号：
- HK09108445.5
- 公开号：
- HK1129595B
- 申请日:
- 2009.09.15
- 申请国别(地区):
- HK
- 年份:
- 2017
- 代理人:
- 摘要：
- Liquid formulation comprising a) an alpha2 adrenoreceptor agonist eg. clonidine, brimonidine, monoxidine, lofexidine； b) oxybutynin； and c) excipients. The liquid formulation is useful for the treatment of siaiorrhoea.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- LIQUID FORMULATING INCLUDING AN ALPHA-2 RECEPTOR AGONIST (E.g. CLONIDIN) AND OXYBUTYNIN (ANTIMUS CARININE) FOR THE TREATMENT OF SPIT
- Combination of alpha-2 receptor agonist (clonidine) and antimuscarinic agent (oxybutynin) for the treatment of fluency
- LIQUID FORMULATION COMPRISING AN ALPHA-2 RECEPTOR AGONIST (E.G. CLONIDIN) AND OXYBUTYNIN (ANTI-MUSCARINIC AGENT) FOR THE TREATMENT OF SIALORRHOEA
- COMBINATION OF ALPHA-2 RECEPTOR AGONIST (CLONIDIN) AND AN ANTI-MUSCARINIC AGENT (OXYBUTYNIN) FOR THE TREATMENT OF SIALORRHOEA
- Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
